Citations 4
Efficacy Of Fremanezumab in Patients With Chronic Migraine With or Without Concomitant Use of Preventive Medication (P4.099)
Silberstein, Stephen D., Yeung, Paul, Blankenbiller, Tricia , Ning, Xiaoping , Yang, Ronghua , Ma, Yuju, Aycardi, Ernesto, Bigal, Marcelo E. , Goadsby, Peter J. , Dodick, David W.
Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available
Impact of Fremanezumab on Headache-related Disability in Patients With Migraine and Documented Inadequate Response to 2–4 Classes of Migraine Preventive Medication Classes in the Open–label Extension of the Phase 3b FOCUS Study (4416)
Starling, Amaal J. , Ramirez-Campos, Verena, Ning, Xiaoping , Cohen, Joshua M. , Yang, Ronghua
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
Efficacy and Disability Outcomes of Fremanezumab in Patients With Prior OnabotulinumtoxinA Treatment Failure: Pooled Results of 3 Randomized, Double-blind, Placebo-controlled Phase 3 Studies (P3-2.004)
Ning, Xiaoping , Campos, Verena Ramirez, Barash, Steve, Krasenbaum, Lynda J., McAllister, Peter , VanderPluym, Juliana H.
Neurology | December 6, 2023 | Volume: 98 | Issue: 18_supplement | Pages: No page available
Long-term safety, tolerability, and efficacy of fremanezumab in migraine
Goadsby, Peter J. , Silberstein, Stephen D., Yeung, Paul, Cohen, Joshua M. , Ning, Xiaoping , Yang, Ronghua , Dodick, David W. , Yeung, Paul P, Goadsby, Peter J , Dodick, David W
Neurology | September 11, 2020 | Volume: 95 | Issue: 18 | Pages: No page available